Danaher surpasses Q1 revenue Estimates23 Apr 2021 02:28
"Revenues from Life Sciences totaled $3,546 million, rising 114.9% year over year. Foreign-currency translations boosted sales by 4%. Core sales including the impact of Cytiva grew 41.5% year over year.
Revenues from Diagnostics grossed $2,178 million, increasing 34% year over year. The improvement came on the back of a 31% rise in core sales."
I wonder what was Beckman Coulter division contribution to Danaher Corp blow out Q1 revenue beat !!!
From COVID tests....using GDR kits.